Ensign Peak Advisors, Inc Bolt Biotherapeutics, Inc. Transaction History

Ensign Peak Advisors, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.41 - $2.91 $26,085 - $53,835	-18,500 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$4.19 - $13.97 $43,613 - $145,413	-10,409 Reduced 36.01%	18,500 $91,000
Q3 2021 Nov 12, 2021	BUY	$11.15 - $18.6 $210,835 - $351,707	18,909 Added 189.09%	28,909 $366,000
Q1 2021 May 12, 2021	BUY	$25.86 - $39.93 $258,600 - $399,300	10,000 New	10,000 $329,000

19.1M

Ticker BOLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,641,500
Market Cap $21.8M
Description
Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-e...

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ensign Peak Advisors, Inc with notifications on news.